Avid Bioservices, Inc. (CDMO)
USD 12.49
(0.0%)
USD 12.49
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -140.75 Million USD | -25234.46% |
| 2023 | 560 Thousand USD | -99.56% |
| 2022 | 127.67 Million USD | 1038.71% |
| 2021 | 11.21 Million USD | 254.52% |
| 2020 | -7.25 Million USD | -72.15% |
| 2019 | -4.21 Million USD | 80.68% |
| 2018 | -21.81 Million USD | 22.54% |
| 2017 | -28.15 Million USD | 49.4% |
| 2016 | -55.65 Million USD | -10.51% |
| 2015 | -50.35 Million USD | -42.41% |
| 2014 | -35.36 Million USD | -18.74% |
| 2013 | -29.78 Million USD | 29.3% |
| 2012 | -42.11 Million USD | -23.33% |
| 2011 | -34.15 Million USD | -135.62% |
| 2010 | -14.49 Million USD | 12.29% |
| 2009 | -16.52 Million USD | 28.7% |
| 2008 | -23.17 Million USD | -11.44% |
| 2007 | -20.79 Million USD | -21.89% |
| 2006 | -17.06 Million USD | -10.41% |
| 2005 | -15.45 Million USD | -7.72% |
| 2004 | -14.34 Million USD | -24.1% |
| 2003 | -11.55 Million USD | 1.36% |
| 2002 | -11.71 Million USD | -22.89% |
| 2001 | -9.53 Million USD | 34.3% |
| 2000 | -14.51 Million USD | 25.57% |
| 1999 | -19.5 Million USD | -65.25% |
| 1998 | -11.8 Million USD | 64.46% |
| 1997 | -33.2 Million USD | -11166.67% |
| 1996 | 300 Thousand USD | 104.35% |
| 1995 | -6.9 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -9.5 Million USD | -354.32% |
| 2024 Q3 | -6 Million USD | 36.84% |
| 2024 Q4 | -123.1 Million USD | -1949.68% |
| 2024 FY | -140.75 Million USD | -25234.46% |
| 2024 Q1 | -2.09 Million USD | -577.35% |
| 2023 Q4 | -309 Thousand USD | -167.03% |
| 2023 Q3 | 461 Thousand USD | 139.88% |
| 2023 FY | 560 Thousand USD | -99.56% |
| 2023 Q1 | 1.56 Million USD | -98.65% |
| 2023 Q2 | -1.15 Million USD | -173.91% |
| 2022 Q4 | 115.59 Million USD | 5042.26% |
| 2022 FY | 127.67 Million USD | 1038.71% |
| 2022 Q1 | 6.3 Million USD | 216.62% |
| 2022 Q2 | 3.52 Million USD | -44.13% |
| 2022 Q3 | 2.24 Million USD | -36.17% |
| 2021 Q3 | 2.2 Million USD | -3.37% |
| 2021 Q1 | 4.73 Million USD | 199.2% |
| 2021 Q2 | 2.28 Million USD | -51.71% |
| 2021 FY | 11.21 Million USD | 254.52% |
| 2021 Q4 | 1.99 Million USD | -9.79% |
| 2020 Q1 | -3.16 Million USD | -1041.67% |
| 2020 Q3 | -2.1 Million USD | -389.3% |
| 2020 Q4 | -4.76 Million USD | -126.62% |
| 2020 FY | -7.25 Million USD | -72.15% |
| 2020 Q2 | -430 Thousand USD | 86.41% |
| 2019 FY | -4.21 Million USD | 80.68% |
| 2019 Q1 | -1.96 Million USD | -164.93% |
| 2019 Q2 | -1.45 Million USD | 26.01% |
| 2019 Q3 | -1.13 Million USD | 21.5% |
| 2019 Q4 | 336 Thousand USD | 129.5% |
| 2018 Q2 | -12.62 Million USD | -947.63% |
| 2018 Q1 | -1.2 Million USD | 77.14% |
| 2018 Q3 | -11 Million USD | 12.83% |
| 2018 FY | -21.81 Million USD | 22.54% |
| 2018 Q4 | 3.02 Million USD | 127.44% |
| 2017 FY | -28.15 Million USD | 49.4% |
| 2017 Q4 | -5.27 Million USD | 32.18% |
| 2017 Q1 | -11.05 Million USD | 6.96% |
| 2017 Q2 | -4.05 Million USD | 63.32% |
| 2017 Q3 | -7.77 Million USD | -91.67% |
| 2016 Q2 | -13.19 Million USD | 3.83% |
| 2016 FY | -55.65 Million USD | -10.51% |
| 2016 Q4 | -11.88 Million USD | 29.46% |
| 2016 Q1 | -13.72 Million USD | -13.09% |
| 2016 Q3 | -16.84 Million USD | -27.65% |
| 2015 Q1 | -13.12 Million USD | -28.11% |
| 2015 Q4 | -12.13 Million USD | 6.61% |
| 2015 FY | -50.35 Million USD | -42.41% |
| 2015 Q3 | -12.99 Million USD | -7.39% |
| 2015 Q2 | -12.1 Million USD | 7.84% |
| 2014 Q3 | -9.72 Million USD | -24.83% |
| 2014 Q2 | -7.79 Million USD | -2.5% |
| 2014 FY | -35.36 Million USD | -18.74% |
| 2014 Q1 | -7.6 Million USD | 10.05% |
| 2014 Q4 | -10.24 Million USD | -5.39% |
| 2013 FY | -29.78 Million USD | 29.3% |
| 2013 Q4 | -8.44 Million USD | -71.94% |
| 2013 Q3 | -4.91 Million USD | 43.86% |
| 2013 Q2 | -8.75 Million USD | -14.21% |
| 2013 Q1 | -7.66 Million USD | 29.57% |
| 2012 Q4 | -10.88 Million USD | 1.88% |
| 2012 Q2 | -12.05 Million USD | -48.97% |
| 2012 Q3 | -11.09 Million USD | 8.0% |
| 2012 Q1 | -8.09 Million USD | 19.19% |
| 2012 FY | -42.11 Million USD | -23.33% |
| 2011 Q4 | -10.01 Million USD | -12.15% |
| 2011 FY | -34.15 Million USD | -135.62% |
| 2011 Q2 | -7.51 Million USD | 2.37% |
| 2011 Q1 | -7.69 Million USD | 0.59% |
| 2011 Q3 | -8.92 Million USD | -18.85% |
| 2010 Q3 | -1.53 Million USD | 44.82% |
| 2010 Q2 | -2.78 Million USD | -14.79% |
| 2010 FY | -14.49 Million USD | 12.29% |
| 2010 Q4 | -7.74 Million USD | -403.32% |
| 2010 Q1 | -2.42 Million USD | 32.72% |
| 2009 Q1 | -5.08 Million USD | 17.42% |
| 2009 Q3 | -3.33 Million USD | 25.91% |
| 2009 Q4 | -3.6 Million USD | -8.31% |
| 2009 FY | -16.52 Million USD | 28.7% |
| 2009 Q2 | -4.49 Million USD | 11.58% |
| 2008 Q3 | -6.15 Million USD | 0.85% |
| 2008 Q4 | -6.15 Million USD | -0.08% |
| 2008 FY | -23.17 Million USD | -11.44% |
| 2008 Q1 | -4.65 Million USD | 11.21% |
| 2008 Q2 | -6.2 Million USD | -33.31% |
| 2007 FY | -20.79 Million USD | -21.89% |
| 2007 Q4 | -5.24 Million USD | -4.36% |
| 2007 Q3 | -5.02 Million USD | 0.89% |
| 2007 Q2 | -5.07 Million USD | 7.09% |
| 2007 Q1 | -5.45 Million USD | -8.32% |
| 2006 Q2 | -4.57 Million USD | -5.35% |
| 2006 Q1 | -4.33 Million USD | 6.83% |
| 2006 FY | -17.06 Million USD | -10.41% |
| 2006 Q3 | -3.11 Million USD | 31.9% |
| 2006 Q4 | -5.03 Million USD | -61.84% |
| 2005 FY | -15.45 Million USD | -7.72% |
| 2005 Q1 | -3.41 Million USD | -7.26% |
| 2005 Q2 | -3.63 Million USD | -6.59% |
| 2005 Q3 | -3.74 Million USD | -2.91% |
| 2005 Q4 | -4.65 Million USD | -24.39% |
| 2004 FY | -14.34 Million USD | -24.1% |
| 2004 Q1 | -4.11 Million USD | -120.07% |
| 2004 Q2 | -2.91 Million USD | 29.09% |
| 2004 Q3 | -4.13 Million USD | -41.92% |
| 2004 Q4 | -3.18 Million USD | 23.08% |
| 2003 Q4 | -1.86 Million USD | 29.51% |
| 2003 Q3 | -2.65 Million USD | 16.93% |
| 2003 Q2 | -3.19 Million USD | 17.16% |
| 2003 FY | -11.55 Million USD | 1.36% |
| 2003 Q1 | -3.85 Million USD | 32.45% |
| 2002 FY | -11.71 Million USD | -22.89% |
| 2002 Q4 | -5.7 Million USD | -53.67% |
| 2002 Q3 | -3.71 Million USD | -22.6% |
| 2002 Q2 | -3.02 Million USD | -520.86% |
| 2002 Q1 | 719 Thousand USD | 131.77% |
| 2001 Q3 | -2.64 Million USD | -3.16% |
| 2001 Q4 | -2.26 Million USD | 14.54% |
| 2001 FY | -9.53 Million USD | 34.3% |
| 2001 Q1 | -2.05 Million USD | 31.75% |
| 2001 Q2 | -2.56 Million USD | -24.79% |
| 2000 FY | -14.51 Million USD | 25.57% |
| 2000 Q1 | -3 Million USD | 63.86% |
| 2000 Q4 | -3.01 Million USD | -7.64% |
| 2000 Q3 | -2.8 Million USD | 50.88% |
| 2000 Q2 | -5.7 Million USD | -90.0% |
| 1999 FY | -19.5 Million USD | -65.25% |
| 1999 Q4 | -8.3 Million USD | -88.64% |
| 1999 Q3 | -4.4 Million USD | -25.71% |
| 1999 Q2 | -3.5 Million USD | -6.06% |
| 1999 Q1 | -3.3 Million USD | -6.45% |
| 1998 FY | -11.8 Million USD | 64.46% |
| 1998 Q4 | -3.1 Million USD | -3.33% |
| 1998 Q3 | -3 Million USD | 11.76% |
| 1998 Q2 | -3.4 Million USD | -47.83% |
| 1998 Q1 | -2.3 Million USD | 92.15% |
| 1997 Q1 | -900 Thousand USD | -140.91% |
| 1997 FY | -33.2 Million USD | -11166.67% |
| 1997 Q4 | -29.3 Million USD | -1992.86% |
| 1997 Q3 | -1.4 Million USD | 6.67% |
| 1997 Q2 | -1.5 Million USD | -66.67% |
| 1996 Q1 | 100 Thousand USD | 105.56% |
| 1996 Q2 | 100 Thousand USD | 0.0% |
| 1996 Q3 | -900 Thousand USD | -1000.0% |
| 1996 Q4 | 2.2 Million USD | 344.44% |
| 1996 FY | 300 Thousand USD | 104.35% |
| 1995 Q1 | -1.7 Million USD | 0.0% |
| 1995 Q4 | -1.8 Million USD | -5.88% |
| 1995 Q3 | -1.7 Million USD | 0.0% |
| 1995 Q2 | -1.7 Million USD | 0.0% |
| 1995 FY | -6.9 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -51.92 Million USD | -171.07% |
| Jaguar Health, Inc. | -41.3 Million USD | -240.806% |
| Keros Therapeutics, Inc. | -152.99 Million USD | 8.0% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -158.633% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 68.028% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 369.88% |
| ContextLogic Inc. | -317 Million USD | 55.598% |
| MiMedx Group, Inc. | 67.43 Million USD | 308.712% |
| MEI Pharma, Inc. | 17.77 Million USD | 891.726% |
| AlloVir, Inc. | -190.41 Million USD | 26.082% |
| Novavax, Inc. | -545.06 Million USD | 74.177% |
| Aptorum Group Limited | -2.82 Million USD | -4883.03% |
| Ardelyx, Inc. | -66.06 Million USD | -113.046% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | 31.432% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -175.128% |
| Vaxcyte, Inc. | -402.26 Million USD | 65.01% |
| Precigen, Inc. | -95.9 Million USD | -46.764% |
| Pharming Group N.V. | -10.54 Million USD | -1234.405% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | 30.179% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -473.495% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -460.97% |
| Avidity Biosciences, Inc. | -212.22 Million USD | 33.676% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -658.936% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -478.295% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -478.295% |
| Bicycle Therapeutics plc | -180.66 Million USD | 22.091% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | 45.409% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -416.752% |
| Acelyrin, Inc. | -381.64 Million USD | 63.119% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -276.95% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -312.753% |
| Senti Biosciences, Inc. | -92.91 Million USD | -51.479% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -34.436% |
| AbCellera Biologics Inc. | -146.39 Million USD | 3.856% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -300.549% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | 21.39% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -2005.505% |
| Chimerix, Inc. | -82.09 Million USD | -71.451% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -379.371% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -593.672% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -215.566% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -175.673% |
| Elevation Oncology, Inc. | -45.7 Million USD | -207.966% |
| Alkermes plc | 355.75 Million USD | 139.564% |
| Fortress Biotech, Inc. | -60.63 Million USD | -132.124% |
| Fortress Biotech, Inc. | -60.63 Million USD | -132.124% |
| Agenus Inc. | -245.76 Million USD | 42.728% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -72.534% |
| Dyadic International, Inc. | -6.79 Million USD | -1971.28% |
| ImmuCell Corporation | -5.77 Million USD | -2337.451% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -14937.714% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -24.603% |
| Lantern Pharma Inc. | -15.96 Million USD | -781.826% |
| Immix Biopharma, Inc. | -15.42 Million USD | -812.437% |
| Incyte Corporation | 597.59 Million USD | 123.553% |
| IO Biotech, Inc. | -86.08 Million USD | -63.508% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -141.458% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -639.681% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -138.635% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | 14.474% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -1555.723% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -91.9% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 62.328% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 75.429% |
| NextCure, Inc. | -62.72 Million USD | -124.404% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -1309.503% |
| Onconetix, Inc. | -37.4 Million USD | -276.247% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -256.526% |
| Opthea Limited | -220.24 Million USD | 36.092% |
| PDS Biotechnology Corporation | -42.94 Million USD | -227.773% |
| PureTech Health plc | -65.69 Million USD | -114.246% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -90.748% |
| Seer, Inc. | -86.27 Million USD | -63.141% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -1122091.492% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -333.286% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -976.763% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -394.703% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -144.732% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -126.091% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -6.234% |
| ChromaDex Corporation | -4.93 Million USD | -2750.405% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -3822.882% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -37.899% |
| CRISPR Therapeutics AG | -153.61 Million USD | 8.37% |
| Precision BioSciences, Inc. | -61.31 Million USD | -129.542% |
| Fate Therapeutics, Inc. | -160.92 Million USD | 12.537% |
| Innoviva, Inc. | 179.72 Million USD | 178.317% |
| Summit Therapeutics Inc. | -614.92 Million USD | 77.111% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -110.095% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -114.024% |
| ESSA Pharma Inc. | -26.58 Million USD | -429.498% |
| GlycoMimetics, Inc. | -36.89 Million USD | -281.45% |
| GT Biopharma, Inc. | -7.59 Million USD | -1752.745% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | 41.684% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 297.105% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -186.549% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -1314.924% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | 42.689% |
| Aptose Biosciences Inc. | -51.2 Million USD | -174.871% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -43.19% |
| Soligenix, Inc. | -6.14 Million USD | -2192.122% |
| Century Therapeutics, Inc. | -136.67 Million USD | -2.985% |
| Kura Oncology, Inc. | -152.63 Million USD | 7.782% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -57.763% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -1235.671% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 24991.329% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -24636.907% |
| Autolus Therapeutics plc | -208.38 Million USD | 32.455% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -95.768% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -98.818% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -549.589% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | 37.513% |
| GRI Bio, Inc. | -13.03 Million USD | -979.643% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -3304.289% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -13.434% |
| IGM Biosciences, Inc. | -246.41 Million USD | 42.88% |
| INmune Bio, Inc. | -30 Million USD | -369.052% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -27.31% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -233.587% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -781.819% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -791.125% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -135.826% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -39.129% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 49.026% |
| Coherus BioSciences, Inc. | -237.89 Million USD | 40.833% |
| Verastem, Inc. | -87.36 Million USD | -61.105% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -159.749% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | 12.758% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -20.654% |
| Histogen Inc. | -10.62 Million USD | -1225.233% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -885.199% |
| Surrozen, Inc. | -43.04 Million USD | -227.013% |
| Organovo Holdings, Inc. | -14.67 Million USD | -859.396% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -2666.9% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -168.926% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -457.151% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -422.507% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -1584.235% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | 6.839% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -187.685% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -373.517% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -1251.094% |
| Apollomics, Inc. | -172.6 Million USD | 18.452% |
| Amarin Corporation plc | -59.11 Million USD | -138.112% |
| Mesoblast Limited | -87.95 Million USD | -60.027% |
| Turnstone Biologics Corp. | -55.2 Million USD | -154.987% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | 4.225% |
| Synaptogenix, Inc. | -6.03 Million USD | -2230.925% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -768.417% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -80.406% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -2837.577% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -1575.193% |
| Exelixis, Inc. | 207.76 Million USD | 167.746% |
| Better Therapeutics, Inc. | -39.76 Million USD | -254.007% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | 2.22% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 73.374% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1056.364% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -1705.755% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -357.748% |
| Gritstone bio, Inc. | -138.49 Million USD | -1.634% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -118.34% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -3418.869% |
| Insmed Incorporated | -749.56 Million USD | 81.222% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -826.646% |
| MediWound Ltd. | -6.71 Million USD | -1995.786% |
| OmniAb, Inc. | -50.61 Million USD | -178.064% |
| Alector, Inc. | -130.39 Million USD | -7.947% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -23.767% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -171.478% |
| Zai Lab Limited | -334.62 Million USD | 57.936% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 56.556% |
| Aura Biosciences, Inc. | -76.4 Million USD | -84.212% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | 40.011% |
| Immunic, Inc. | -93.61 Million USD | -50.358% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -3.576% |
| Veracyte, Inc. | -74.4 Million USD | -89.174% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -1733.784% |
| FibroGen, Inc. | -284.23 Million USD | 50.48% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -436.57% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -1910.214% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -647.386% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 133.93% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -524.043% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 385.671% |
| TG Therapeutics, Inc. | 12.67 Million USD | 1210.74% |
| Galecto, Inc. | -38.34 Million USD | -267.032% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -646.067% |
| Fortrea Holdings Inc. | -3.4 Million USD | -4039.794% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -11.141% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -708.414% |
| XBiotech Inc. | -24.55 Million USD | -473.169% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -118.34% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -124.558% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -43.004% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -556.896% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -155.02% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 76.798% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -106.216% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -247121.344% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | 37.868% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -532.1% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | 35.937% |
| NexImmune, Inc. | -32.34 Million USD | -335.17% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -2562.462% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -902.093% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 103.56% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -481.12% |
| Scopus BioPharma Inc. | -11.6 Million USD | -1112.361% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -20.51% |
| Ainos, Inc. | -13.77 Million USD | -922.131% |
| Pluri Inc. | -20.88 Million USD | -573.846% |
| Prothena Corporation plc | -147.02 Million USD | 4.268% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -23.607% |
| Celularity Inc. | -196.29 Million USD | 28.295% |
| Rallybio Corporation | -74.56 Million USD | -88.768% |
| Cue Biopharma, Inc. | -50.73 Million USD | -177.439% |
| MeiraGTx Holdings plc | -84.02 Million USD | -67.509% |
| Omeros Corporation | -117.81 Million USD | -19.472% |
| Humacyte, Inc. | -110.77 Million USD | -27.061% |
| Immunocore Holdings plc | -55.28 Million USD | -154.586% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -682.657% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -513.811% |
| Blueprint Medicines Corporation | -506.98 Million USD | 72.237% |
| CalciMedica, Inc. | -34.35 Million USD | -309.678% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -107.984% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | 0.461% |
| Scholar Rock Holding Corporation | -165.78 Million USD | 15.101% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 50.309% |
| Pulmatrix, Inc. | -14.12 Million USD | -896.764% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -299.923% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -70.325% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 70.749% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -34.215% |
| Cytokinetics, Incorporated | -526.24 Million USD | 73.253% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -290.276% |
| Nutriband Inc. | -5.48 Million USD | -2465.997% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -248.226% |
| Vor Biopharma Inc. | -117.86 Million USD | -19.421% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 103.237% |
| Evogene Ltd. | -23.87 Million USD | -489.443% |
| ProKidney Corp. | -35.46 Million USD | -296.845% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -17.526% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -1694.085% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 78.117% |
| CorMedix Inc. | -46.33 Million USD | -203.745% |
| BioLineRx Ltd. | -60.61 Million USD | -132.212% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -38.34% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -242.748% |
| Atai Life Sciences N.V. | -40.22 Million USD | -249.923% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -74.523% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -86.376% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 51.828% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -404.925% |
| MediciNova, Inc. | -8.57 Million USD | -1542.102% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -14.176% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -1580.265% |
| GeoVax Labs, Inc. | -25.96 Million USD | -442.051% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | 41.166% |
| Biomea Fusion, Inc. | -117.25 Million USD | -20.04% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 77.537% |
| Mereo BioPharma Group plc | -29.46 Million USD | -377.679% |
| Cullinan Oncology, Inc. | -153.16 Million USD | 8.102% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | 32.77% |
| Absci Corporation | -110.56 Million USD | -27.302% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -366.842% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -39.585% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | 40.343% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 1099.382% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | 27.057% |
| Allakos Inc. | -185.7 Million USD | 24.205% |
| Imunon, Inc. | -19.51 Million USD | -621.256% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -44.607% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 232.611% |
| BioAtla, Inc. | -123.46 Million USD | -14.005% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1056.364% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -775.438% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 56.991% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -280.939% |
| XOMA Corporation | -40.83 Million USD | -244.721% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -38.169% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -18.766% |
| aTyr Pharma, Inc. | -50.38 Million USD | -179.333% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -60.532% |
| Akero Therapeutics, Inc. | -151.75 Million USD | 7.252% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | 40.794% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -300.789% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -1639.422% |
| Akari Therapeutics, Plc | -10 Million USD | -1306.405% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -208964.983% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 149.984% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -2011.855% |
| UroGen Pharma Ltd. | -102.24 Million USD | -37.664% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -31.8% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -1709.82% |
| Orgenesis Inc. | -55.36 Million USD | -154.246% |
| Entera Bio Ltd. | -8.88 Million USD | -1483.451% |
| GH Research PLC | -35.58 Million USD | -295.518% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -575.398% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -81.88% |
| Xencor, Inc. | -126.08 Million USD | -11.632% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -3637.763% |
| Replimune Group, Inc. | -215.79 Million USD | 34.774% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -561.852% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 5709.924% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -2011.855% |
| Portage Biotech Inc. | -75.33 Million USD | -86.826% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -1580.265% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -45.624% |
| OncoCyte Corporation | -27.78 Million USD | -406.652% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -949.048% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -1165.591% |
| Purple Biotech Ltd. | -19.88 Million USD | -608.013% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -1905.314% |
| scPharmaceuticals Inc. | -54.81 Million USD | -156.802% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -704.021% |
| HilleVax, Inc. | -123.56 Million USD | -13.909% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -1292.629% |
| Tharimmune, Inc. | -9.31 Million USD | -1410.372% |
| Genprex, Inc. | -30.86 Million USD | -356.095% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | 40.34% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -367.711% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -7798.597% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -2557.715% |
| OKYO Pharma Limited | -16.82 Thousand USD | -836447.708% |
| Savara Inc. | -54.69 Million USD | -157.328% |
| Curis, Inc. | -47.41 Million USD | -196.866% |
| Daré Bioscience, Inc. | -30.16 Million USD | -366.666% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -811.312% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -2427.438% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -372.088% |
| BeiGene, Ltd. | -881.7 Million USD | 84.036% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -560.998% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 67.744% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -78.27% |
| Erasca, Inc. | -125.04 Million USD | -12.565% |
| bluebird bio, Inc. | -211.91 Million USD | 33.58% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -2714.78% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 183.959% |
| DBV Technologies S.A. | -72.72 Million USD | -93.539% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -2714.78% |
| Moderna, Inc. | -4.71 Billion USD | 97.014% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -250.507% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -2371.953% |
| Molecular Templates, Inc. | -8.12 Million USD | -1632.558% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -133.081% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -26.35% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -3.99% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -193.731% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | 0.478% |
| Cogent Biosciences, Inc. | -192.41 Million USD | 26.847% |
| MacroGenics, Inc. | -9.05 Million USD | -1453.908% |
| RenovoRx, Inc. | -10.23 Million USD | -1275.616% |
| Adicet Bio, Inc. | -142.65 Million USD | 1.335% |
| Prime Medicine, Inc. | -198.13 Million USD | 28.96% |
| Aditxt, Inc. | -32.38 Million USD | -334.68% |
| Adagene Inc. | -18.94 Million USD | -642.902% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -1825.032% |
| Quantum-Si incorporated | -95.96 Million USD | -46.679% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -18.251% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -865.532% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 206.365% |
| SciSparc Ltd. | -5.12 Million USD | -2648.009% |
| Vericel Corporation | -3.18 Million USD | -4323.413% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -116946.418% |
| Minerva Neurosciences, Inc. | -30 Million USD | -369.093% |
| Generation Bio Co. | -126.61 Million USD | -11.169% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -93.101% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -70.73% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | 46.306% |
| Invivyd, Inc. | -198.64 Million USD | 29.143% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 58.841% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -1520.351% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 717.175% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -1325.491% |
| 2seventy bio, Inc. | -217.57 Million USD | 35.307% |
| ADMA Biologics, Inc. | -28.23 Million USD | -398.435% |
| Clene Inc. | -49.5 Million USD | -184.327% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -531.532% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -184.729% |
| GeoVax Labs, Inc. | -25.96 Million USD | -442.051% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 57.096% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -332.515% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 719.511% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -42.474% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -88.288% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | 12.47% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 77.116% |
| Evaxion Biotech A/S | -22.12 Million USD | -536.172% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -74.337% |
| Verve Therapeutics, Inc. | -200.06 Million USD | 29.647% |
| Trevena, Inc. | -40.28 Million USD | -249.358% |
| Surrozen, Inc. | -43.04 Million USD | -227.013% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -103.594% |
| Cingulate Inc. | -23.53 Million USD | -498.06% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -1936.357% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -253.118% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -1725.431% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -56.028% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -129.666% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -136.548% |
| Clearmind Medicine Inc. | -11.95 Million USD | -1077.354% |
| Kronos Bio, Inc. | -112.67 Million USD | -24.922% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -103.409% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -5549593.837% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -63.866% |
| Statera Biopharma, Inc. | -174.4 Million USD | 19.297% |
| ImmunityBio, Inc. | -583.19 Million USD | 75.865% |
| Korro Bio, Inc. | -81.17 Million USD | -73.401% |
| Kineta, Inc. | -14.09 Million USD | -898.319% |
| BioVie Inc. | -32.12 Million USD | -338.203% |
| Codexis, Inc. | -76.24 Million USD | -84.618% |
| Celularity Inc. | -196.29 Million USD | 28.295% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | 34.39% |
| Celcuity Inc. | -63.77 Million USD | -120.688% |
| Virax Biolabs Group Limited | -6.73 Million USD | -1990.328% |
| Cibus, Inc. | -267.62 Million USD | 47.407% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -249.038% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -293.044% |
| IN8bio, Inc. | -30 Million USD | -369.067% |
| Kodiak Sciences Inc. | -260.49 Million USD | 45.966% |
| Annexon, Inc. | -134.23 Million USD | -4.854% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -20.132% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -129.883% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -346.212% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 61.573% |
| Eyenovia, Inc. | -27.26 Million USD | -416.315% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 751.906% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -26208.972% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -84.222% |
| Arcellx, Inc. | -70.69 Million USD | -99.113% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -239.647% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -5.184% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -368.599% |
| Moolec Science SA | -51.78 Million USD | -171.782% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -168.761% |
| Geron Corporation | -184.12 Million USD | 23.557% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -235.334% |
| Royalty Pharma plc | 1.13 Billion USD | 112.403% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -3.528% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -1482.952% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -562.578% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | 18.01% |
| Humacyte, Inc. | -110.77 Million USD | -27.061% |
| Structure Therapeutics Inc. | -89.62 Million USD | -57.055% |
| 89bio, Inc. | -142.18 Million USD | 1.01% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -104.108% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -1256.394% |
| Genelux Corporation | -28.29 Million USD | -397.413% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -384.27% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | 20.532% |
| Notable Labs, Ltd. | -11.26 Million USD | -1149.583% |
| Liquidia Corporation | -78.5 Million USD | -79.299% |
| Mustang Bio, Inc. | -51.6 Million USD | -172.767% |
| Immunovant, Inc. | -259.33 Million USD | 45.726% |
| Quantum-Si incorporated | -95.96 Million USD | -46.679% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -93.212% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -626.242% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -46.633% |
| Acasti Pharma Inc. | -12.85 Million USD | -995.098% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -526.743% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -781.819% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | 22.83% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -3172.171% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -1028.733% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -377.274% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -261.016% |
| PepGen Inc. | -78.62 Million USD | -79.016% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -372.817% |
| United Therapeutics Corporation | 984.8 Million USD | 114.293% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -532.314% |
| Solid Biosciences Inc. | -96.01 Million USD | -46.595% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -2837.577% |
| Immuneering Corporation | -53.47 Million USD | -163.229% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -2666.9% |
| Silo Pharma, Inc. | -3.7 Million USD | -3703.433% |
| Belite Bio, Inc | -31.63 Million USD | -344.97% |
| XOMA Corporation | -40.83 Million USD | -244.721% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -158.904% |
| Bionomics Limited | -15.49 Billion USD | 99.091% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -67.593% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -382.742% |
| uniQure N.V. | -308.47 Million USD | 54.372% |
| Cassava Sciences, Inc. | -97.21 Million USD | -44.782% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -1825.032% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -14.035% |
| Forte Biosciences, Inc. | -31.47 Million USD | -347.176% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -1616.144% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -384.22% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -26208.972% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -436.57% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -753.825% |
| Altimmune, Inc. | -88.44 Million USD | -59.138% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | 7.145% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -382.742% |
| Compugen Ltd. | -18.75 Million USD | -650.523% |
| Peak Bio, Inc. | -1259.26 USD | -11177337.543% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -205.659% |
| Benitec Biopharma Inc. | -21.75 Million USD | -547.11% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 58.454% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -69.676% |
| Zura Bio Limited | -60.36 Million USD | -133.189% |
| PolyPid Ltd. | -23.86 Million USD | -489.788% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -794.692% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -69.676% |
| Instil Bio, Inc. | -156.08 Million USD | 9.824% |
| argenx SE | -295.05 Million USD | 52.296% |
| Immunome, Inc. | -106.8 Million USD | -31.784% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -231.23% |
| Verona Pharma plc | -54.36 Million USD | -158.885% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -40.87% |
| Shattuck Labs, Inc. | -87.29 Million USD | -61.233% |
| CervoMed Inc. | -2.17 Million USD | -6380.72% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -12.918% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -957.022% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -223.162% |
| Moolec Science SA | -51.78 Million USD | -171.782% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -813890.272% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -4.171% |
| AnaptysBio, Inc. | -163.61 Million USD | 13.975% |
| Design Therapeutics, Inc. | -66.86 Million USD | -110.513% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -72.885% |
| NeurAxis, Inc. | -14.62 Million USD | -862.303% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -271.556% |
| Lumos Pharma, Inc. | -34.03 Million USD | -313.566% |
| Achilles Therapeutics plc | -69.66 Million USD | -102.043% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -40.87% |
| 180 Life Sciences Corp. | -19.93 Million USD | -606.056% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 4778.06% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -5549593.837% |
| Nutriband Inc. | -5.48 Million USD | -2465.997% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -39.779% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -189.574% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -82.58% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -314.345% |
| MoonLake Immunotherapeutics | -36 Million USD | -290.902% |
| Palisade Bio, Inc. | -12.3 Million USD | -1044.333% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -234.14% |
| Beam Therapeutics Inc. | -132.52 Million USD | -6.207% |
| Neurogene Inc. | -36.31 Million USD | -287.568% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | 13.868% |
| AEON Biopharma, Inc. | -52.55 Million USD | -167.815% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -43.41% |
| Sesen Bio, Inc. | -19.88 Million USD | -607.871% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -96.626% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -1024.774% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 68.302% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -26.161% |
| Athira Pharma, Inc. | -117.67 Million USD | -19.615% |
| Vaccinex, Inc. | -20.25 Million USD | -595.042% |
| HCW Biologics Inc. | -24.99 Million USD | -463.141% |
| XOMA Corporation | -40.83 Million USD | -244.721% |
| Nektar Therapeutics | -276.05 Million USD | 49.013% |
| Arvinas, Inc. | -367.3 Million USD | 61.679% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -208964.983% |
| Merus N.V. | -154.93 Million USD | 9.156% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -44.469% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -348.472% |
| Rezolute, Inc. | -68.45 Million USD | -105.602% |
| Clene Inc. | -49.5 Million USD | -184.327% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -812.59% |
| BeyondSpring Inc. | -21.02 Million USD | -569.424% |
| Synlogic, Inc. | -57.28 Million USD | -145.719% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -1082.699% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -1200.139% |
| Peak Bio, Inc. | -1259.26 USD | -11177337.543% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -276.667% |
| Krystal Biotech, Inc. | 10.93 Million USD | 1387.532% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | 1.639% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 56.705% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -2947.284% |
| MannKind Corporation | -11.93 Million USD | -1079.033% |
| Ikena Oncology, Inc. | -68.16 Million USD | -106.486% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -569.774% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -51.456% |
| Gossamer Bio, Inc. | -179.81 Million USD | 21.724% |
| CohBar, Inc. | -11.96 Million USD | -1076.656% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -445.808% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -366.842% |
| Legend Biotech Corporation | -518.25 Million USD | 72.841% |
| Mural Oncology plc | -207.44 Million USD | 32.15% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -13.405% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -669.574% |
| Disc Medicine, Inc. | -76.42 Million USD | -84.162% |
| Champions Oncology, Inc. | -7.27 Million USD | -1834.483% |
| REGENXBIO Inc. | -263.49 Million USD | 46.582% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -1226.223% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -196.291% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -270.564% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -40.524% |
| Vaxart, Inc. | -82.46 Million USD | -70.682% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 42271.541% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -274.916% |
| Cellectis S.A. | -101.05 Million USD | -39.278% |
| Longeveron Inc. | -21.41 Million USD | -557.325% |
| Repare Therapeutics Inc. | -93.79 Million USD | -50.063% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 73.739% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -97.773% |
| Revolution Medicines, Inc. | -436.36 Million USD | 67.744% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -2042.033% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -356.634% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -103.01% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -117.44% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -1334.645% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 103.889% |
| Denali Therapeutics Inc. | -145.22 Million USD | 3.079% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -116946.418% |
| Veru Inc. | -93.15 Million USD | -51.099% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -420.748% |
| Cingulate Inc. | -23.53 Million USD | -498.06% |
| Passage Bio, Inc. | -102.06 Million USD | -37.909% |
| Context Therapeutics Inc. | -23.96 Million USD | -487.347% |
| Exicure, Inc. | -16.91 Million USD | -732.169% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | 25.495% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -272.717% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -2062.993% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | 23.785% |
| Nuvalent, Inc. | -126.21 Million USD | -11.515% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -1238.509% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -62.01% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -360.82% |
| OmniAb, Inc. | -50.61 Million USD | -178.064% |
| Anew Medical, Inc. | 1.34 Million USD | 10556.161% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -777.239% |
| Lipocine Inc. | -16.35 Million USD | -760.765% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -111.997% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -121.049% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -233.587% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -193.437% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -609.762% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 74.006% |
| Ocugen, Inc. | -63.07 Million USD | -123.141% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -47.028% |
| Q32 Bio Inc. | -112.96 Million USD | -24.603% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -718.712% |
| Alumis Inc. Common Stock | -154.99 Million USD | 9.188% |
| Equillium, Inc. | -13.33 Million USD | -955.516% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -133.166% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -1662.092% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -646.652% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -138.233% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -22.899% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -665.88% |
| Dominari Holdings Inc. | -22.88 Million USD | -515.125% |
| Edesa Biotech, Inc. | -8.37 Million USD | -1580.75% |
| vTv Therapeutics Inc. | -20.25 Million USD | -595.077% |
| Bio-Techne Corporation | 168.1 Million USD | 183.729% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 60.023% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 209.235% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -15.53% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -270.998% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -24.956% |
| Nkarta, Inc. | -117.5 Million USD | -19.789% |
| BioCardia, Inc. | -11.57 Million USD | -1116.429% |
| Iterum Therapeutics plc | -38.37 Million USD | -266.821% |